Objectives. Both increased and decreased apoptosis may be involved in gener
ating autoimmunity. This study addressed the question of whether apoptosis
and apoptosis-regulating proteins are altered in systemic sclerosis (SSc).
Patients and methods. Peripheral lymphocytes of 39 SSc patients and 47 heal
thy control persons were studied for apoptosis, Bcl-2 and Bax levels, expre
ssion of Fas (CD95) and activation markers (CD25, HLA-DR) as determined by
fluorocytometry. Serum Fas and Fas ligand were measured by ELISA.
Results. SSc lymphocytes (mainly CD4(+)) expressed increased amounts of Bcl
-2, while Bar was not elevated. Apoptosis rates of SSc lymphocytes were inc
reased in unsupplemented medium, but returned to normal in the presence of
autologous plasma. SSc patients had increased percentages of activated and
CD95(+) lymphocytes and elevated soluble Fas and soluble FasL levels in ser
um. Activating anti-CD95 antibodies further increased the apoptosis rate.
Conclusions. Increased in vitro apoptosis, elevated lymphocytic Bcl-2 conte
nt and the increased number of Fas-positive T cells are not specific for pe
ripheral blood from SSc patients, but indicate deregulation of lymphocyte h
omeostasis in this disease.